{
    "title": "108_hr3359",
    "content": "The Act is titled the \"Prevention, Awareness, and Research Auto-Immune Disease Act\". The Lupus Foundation of America estimates that 1.5 million Americans have lupus, with 9 out of 10 being women. Early diagnosis and treatment can prevent serious organ damage and disability. 1 in 5 lupus sufferers receive disability payments, costing the Government billions each year. The average annual cost of medical treatment for an individual with lupus is $6,000 to $10,000, with some facing costs exceeding several thousand dollars monthly. Public awareness and understanding of lupus are low, with only 1 in 5 Americans able to provide basic information about the disease. Awareness is lowest among adults aged 18 to 34, the group most likely to develop symptoms. Multiple sclerosis, a chronic and disabling disease of the central nervous system, is twice as common in women as in men and often first appears in individuals aged 20 to 50, leading to lifelong physical and emotional effects. Multiple sclerosis is more common in women than men, with an estimated 250,000 to 400,000 affected individuals in the US. The annual cost per affected individual is around $50,000, totaling over $3,000,000 in a lifetime. The total annual cost of treating all MS patients in the US is approximately $20,000,000,000. Symptoms can range from mild numbness to severe paralysis or vision loss. The progression and specific symptoms of MS are unpredictable. Arthritis is the leading cause of disability in the US. Arthritis is the primary cause of disability in the US, with rheumatoid arthritis affecting 2.1 million people, mostly women. The direct costs of rheumatoid arthritis amount to $1.2 billion annually, with average lifetime medical care expenses ranging from $225,000 to $370,000. Fibromyalgia, affecting 3.7 million Americans, is more common in women and its exact cause is unknown. Rheumatoid arthritis and fibromyalgia are conditions that affect millions of Americans, with triggers including stress, trauma, or possibly an infectious agent in susceptible individuals. SEC. 3. GRANTS TO INCREASE AWARENESS OF AUTOIMMUNE DISEASES. The purpose of this section is to increase awareness of autoimmune diseases like lupus, multiple sclerosis, rheumatoid arthritis, and fibromyalgia, which affect 5 to 10 percent of the US population. Grants will be awarded to conduct awareness activities through the Centers for Disease Control and Prevention. The eligible entity receiving a grant can promote awareness of early intervention and treatment for autoimmune diseases like lupus, multiple sclerosis, rheumatoid arthritis, and fibromyalgia. They can target minority communities and women to reduce the time for correct diagnosis. The eligible entity receiving a grant can promote awareness of early intervention and treatment for autoimmune diseases, reducing the time for correct diagnosis, which often takes more than 1 year. An eligible entity is defined as a nonprofit organization, a consumer group, an institution of higher education, a governmental agency, or a media organization. $18,000,000 is authorized for each of fiscal years 2004 and 2005 to carry out this section. Grants are provided for education on the relationship between autoimmune diseases and mental illnesses. Title III of the Public Health Service Act is amended to include grants for educating healthcare providers on the potential links between autoimmune diseases like lupus, multiple sclerosis, rheumatoid arthritis, and fibromyalgia, and cognitive and mood disorders such as depression. Eligible entities for these grants include nonprofit organizations, consumer groups, institutions of higher education, governmental agencies, and media organizations. Authorization of Appropriations: $5,000,000 for each of fiscal years 2004 and 2005 is authorized to carry out grants for educating healthcare providers on the potential links between autoimmune diseases and cognitive and mood disorders. SEC. 5. Loan Repayment Program for Physician Research on Autoimmune Diseases is added to Title IV of the Public Health Service Act. The Secretary will establish a program for qualified physicians to conduct research on autoimmune diseases in exchange for repayment of up to $35,000 of their educational loans per year. This program falls under Title IV of the Public Health Service Act. The program established under this section allows qualified physicians to conduct research on autoimmune diseases in exchange for loan repayment. Qualified physicians are individuals with a doctor of medicine degree licensed to practice in the US. Funding for this program is authorized annually. The program allows qualified physicians to conduct research on autoimmune diseases in exchange for loan repayment. Funding for this program remains available until the second fiscal year after the initial allocation."
}